As filed with the Securities and Exchange Commission on February 15, 2001

                                     Registration No. 333-



                 SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549


                              FORM S-8
                       REGISTRATION STATEMENT
                                Under
                     The Securities Act of 1933

                    CORGENIX MEDICAL CORPORATION
       (Exact name of registrant as specified in its charter)

             Nevada                            93-1223466
 (State or other jurisdiction of            (I.R.S. Employer
 incorporation or organization)          Identification Number)


                         12061 Tejon Street
                     Westminster, Colorado 80234
                           (303) 457-4345
(Address,   including zip code,  and telephone  number,  including area code, of
            registrant's principal executive offices)

                     Employee Stock Purchase Plan
                       Stock Compensation Plan
                      1999 Incentive Stock Plan
                        (Full title of plan)



     Douglass T. Simpson                       With a copy to:
          President                       Lester R. Woodward, Esq.
     12061 Tejon Street                   Davis Graham & Stubbs LLP
 Westminster, Colorado 80234             1550 17th Street, Suite 500
       (303) 457-4345                      Denver, Colorado  80202

      (Name, address, including zip code, and telephone number,
             including area code, of agent for service)





                   CALCULATION OF REGISTRATION FEE
==================================================================

                               Proposed         Proposed
  Title of      Amount to be   maximum           maximum           Amount of
each class of    registered  offering price  aggregate offering  registration
securities to be              per share(1)       price(1)            fee
  registered

- ------------------------------------------------------------------
- ------------------------------------------------------------------

Common Stock   1,250,000 shares $0.175          $218,750              $55
($.001 par value)
==================================================================

(1)Estimated   solely  for  the  purposes  of  calculating  the  amount  of  the
   registration  fee pursuant to Rule 457(h).  The price per share and aggregate
   offering  price are based upon the  average of the bid and asked price of the
   Company's  Common  Stock on February 12, 2001 as reported on the OTC Bulletin
   Board(R).







                               PART II

              INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

3.    Incorporation of Documents by Reference.

      The  following  documents  filed  or  to  be  filed  by  Corgenix  Medical
Corporation  (the  "Company")  with the Securities and Exchange  Commission (the
"Commission")  are  hereby  incorporated  or deemed to be  incorporated  in this
Registration Statement by reference:

      (a) The  Company's  Annual Report on Form 10-KSB for the fiscal year ended
June 30, 2000, filed with the Commission on October 2, 2000.

      (b) The  Company's  Quarterly  Report on Form 10-QSB for the quarter ended
December 31, 2000, filed with the Commission on February 6, 2001.

      (c)  The  description  of the  Company's  Common  Stock  contained  in the
Company's Registration Statement on Form 10-SB/A-2, filed with the Commission on
November 3, 1998.

           All other documents filed by the Company with the Commission pursuant
to Sections 13(a),  13(c),  14 and 15(d) of the Securities  Exchange Act of 1934
subsequent to the date of this Registration Statement and prior to the filing of
a post-effective  amendment to this Registration  Statement  indicating that all
securities  offered  under  the  Registration   Statement  have  been  sold,  or
deregistering  all  securities  then  remaining  unsold,  shall be  deemed to be
incorporated  by reference in the  Registration  Statement and to be part hereof
from the date of filing such documents.

      Any  statement  contained  in a  document  incorporated,  or  deemed to be
incorporated,  by reference  herein shall be deemed to be modified or superseded
for  purposes  of this  Registration  Statement  to the extent  that a statement
contained herein or in any other subsequently filed document which also is or is
deemed to be  incorporated  by  reference  herein  modifies or  supersedes  such
statement.  Any statement so modified or superseded shall not be deemed,  except
as so  modified  or  superseded,  to  constitute  a part  of  this  Registration
Statement.

4.    Description of Securities.

      Not applicable.

5.    Interests of Named Experts and Counsel.

      Not applicable.


6.    Indemnification of Directors and Officers.

      Section 78.7502 of the Nevada General  Corporation  Law ("NGCL")  permits,
subject to  certain  conditions,  a  corporation  to  indemnify  its  directors,
officers,  employees and agents against expenses  (including  attorneys'  fees),
judgements,  fines  and  amounts  paid in  settlement  actually  and  reasonably
incurred by such  director,  officer,  employee or agent in connection  with the
threatened,  pending or  completed  actions,  suits or  proceedings  (other than
actions  by or in the  right  of the  corporation)  in or to  which  any of such
persons is a party or is threatened to be made a party.

      Our articles of incorporation  contain certain provisions  permitted under
the NGCL relating to the liability of directors,  officers and employees.  These
provisions  eliminate a  director's  personal  liability  for  monetary  damages
resulting from a breach of a fiduciary  duty,  except in connection with acts or
omissions that involve intentional  misconduct,  fraud or a knowing violation of
law, or the payment of  dividends in violation  of Nevada  corporate  law.  This
provision  also does not affect a  director's  responsibilities  under any other
laws, such as the federal securities laws.

      The articles of  incorporation  and our by-laws  also  contain  provisions
indemnifying  our directors  and executive  officers and may indemnify its other
officers,  employees and agents to the fullest  extent not  prohibited by Nevada
law. The Company has also entered into  indemnification  agreements with each of
its  directors  and  officers.  The  Company  is  empowered  under its Bylaws to
purchase  insurance  on behalf of any  person it is  required  or  permitted  to
indemnify.

      There is no pending  litigation  or  proceeding  involving  a director  or
officer of the Company as to which  indemnification  is being sought, nor is the
Company aware of any pending or threatened  litigation that may result in claims
for indemnification by any director or officer.

7.    Exemption from Registration Claimed.

      Not applicable.

8.    Exhibits

     4.1   Employee Stock Purchase Plan. 1/
                                         -

     4.2   Stock Compensation Plan.

     4.3   1999 Incentive Stock Plan. 1/
                                      -

     5.1   Opinion and Consent of Davis, Graham & Stubbs LLP.

    23.1   Consent of Davis, Graham & Stubbs LLP (included in Exhibit 5.1).

    23.2   Consent of KPMG LLP.

    24.1   Power of Attorney (included in signature page).


- --------
1/    Filed  previously as an Exhibit to the Company's  Proxy  Statement on Form
      14A, as filed with the  Commission on October 28, 1999,  and  incorporated
      herein by reference.


9.    Undertakings

      A. The undersigned  Registrant hereby undertakes:  (1) to file, during any
period in which it offers or sells  securities,  a  post-effective  amendment to
this Registration  Statement to include any material information with respect to
the plan of  distribution,  or any material  change to such  information  in the
Registration  Statement;  (2) that, for the purpose of determining any liability
under the Securities Act of 1933,  each such  post-effective  amendment shall be
deemed to be a new  Registration  Statement  relating to the securities  offered
therein,  and the offering of such securities at that time shall be deemed to be
the initial bona fide offering  thereof;  and (3) to remove from registration by
means of a post-effective amendment any of the securities being registered which
remain unsold at the termination of the offering.

      B. The  undersigned  Registrant  hereby  undertakes  that, for purposes of
determining  any liability  under the Securities Act of 1933, each filing of the
Company's  annual  report  pursuant  to Section  13(a) or  Section  15(d) of the
Securities  Exchange  Act of  1934  that is  incorporated  by  reference  in the
Registration  Statement  shall  be  deemed  to be a new  Registration  Statement
relating to the securities offered therein,  and the offering of such securities
at that time shall be deemed to be the initial bona fide offering thereof.

      C. Insofar as indemnification for liabilities arising under the Securities
Act of 1933 may be permitted to directors,  officers and controlling  persons of
the Company pursuant to the foregoing provisions,  or otherwise, the Company has
been advised that in the opinion of the Securities and Exchange  Commission such
indemnification  is  against  public  policy  as  expressed  in the  Act and is,
therefore,  unenforceable. In the event that a claim for indemnification against
such liabilities  (other than the payment by the Company of expenses incurred or
paid  by a  director,  officer  or  controlling  person  of the  Company  in the
successful  defense of any  action,  suit or  proceeding)  is  asserted  by such
director,  officer or controlling person in connection with the securities being
registered,  the Company  will,  unless in the opinion of its counsel the matter
has been  settled by  controlling  precedent,  submit to a court of  appropriate
jurisdiction the question whether such  indemnification  by it is against public
policy as expressed in the Act and will be governed by the final adjudication of
such issue.





                             SIGNATURES

      Pursuant to the  requirements  of the  Securities Act of 1933, the Company
certifies  that it has  reasonable  grounds to believe  that it meets all of the
requirements  for  filing  on Form S-8 and has  duly  caused  this  Registration
Statement  to be  signed  on its  behalf  by  the  undersigned,  thereunto  duly
authorized,  in the City of Westminster,  State of Colorado,  on the 15th day of
February, 2001.

                                 CORGENIX MEDICAL CORPORATION


                                 By: s/ Luis R. Lopez, M.D.
                                     ------------------------------
                                    Dr. Luis R. Lopez
                                    Chairman  of the Board and Chief  Executive
                                    Officer

                          POWER OF ATTORNEY

           KNOW ALL PERSONS BY THESE PRESENTS,  that each person whose signature
appears  below  constitutes  and appoints Luis R. Lopez and Douglass T. Simpson,
and each or any of them, his true and lawful  attorney-in-fact  and agent,  with
full power of substitution  and  resubstitution,  for him and in his name, place
and stead, in any and all capacities,  to sign any and all amendments (including
post-effective  amendments and any registration statement filed pursuant to Rule
462(b)  under the  Securities  Act of 1933,  as  amended)  to this  Registration
Statement,  and to file the same, with all exhibits thereto, and other documents
in connection therewith,  with the Securities and Exchange Commission,  granting
unto  said  attorneys-in-fact  and  agents,  and each of them,  full  power  and
authority to do and perform each and every act and thing requisite and necessary
to be done in connection  therewith,  as fully to all intents and purposes as he
might or could do in  person,  hereby  ratifying  and  confirming  all that said
attorney-in-fact  and agents,  or any of them,  or their or his  substitutes  or
substitute, may lawfully do or cause to be done by virtue hereof.

      Pursuant to the  requirements  of the  Securities Act of 1933, as amended,
this  Registration  Statement  has been signed by the  following  persons in the
capacities and on the date indicated.

- -------------------------------------------------------------------------

Signatures                 Title                 Date
- -------------------------------------------------------------------------
- -------------------------------------------------------------------------



S/ Luis R. Lopez, M.D      Chairman of the       February 15, 2001
- -----------------------
Luis R. Lopez, M.D.        Board, Chief
                           Executive Officer
                           and Director
                           (principal executive
                           officer)
- -------------------------------------------------------------------------
- -------------------------------------------------------------------------


S/ Douglass T. Simpson     President (principal  February 15, 2001
- -----------------------
Douglass T. Simpson        financial and
                           accounting officer)
                           and Director
- -------------------------------------------------------------------------
- -------------------------------------------------------------------------



S/ Brian E. Johnson        Director              February 15, 2001
- -----------------------
Brian E. Johnson
- -------------------------------------------------------------------------
- -------------------------------------------------------------------------



- -------------------------------------------------------------------------






                                  EXHIBIT INDEX

Exhibit
  No.      Description

4.2        Stock Compensation Plan.

5.1        Opinion and Consent of Davis, Graham & Stubbs LLP.

23.1       Consent of Davis, Graham & Stubbs LLP (included in Exhibit 5.1).

23.2       Consent of KPMG Peat Marwick LLP.

24.1       Power of Attorney (included in signature page).